Login / Signup

HER2-low in gastro-oesophageal adenocarcinoma: a real-world pathological perspective.

Valentina AngerilliPaola ParenteMichela CamporaClara UgoliniSerena BattistaPaola CassoniAlessandro GambellaFrancesco CavallinGiuseppe De LisiAlessandro VanoliFederica GrilloLuca MastracciAngelo Paolo Dei Tos
Published in: Journal of clinical pathology (2023)
This work shows how the expansion of the HER2 spectrum might raise problems in reproducibility, especially in biopsy specimens, decreasing interlaboratory and interobserver concordance. If controlled trials confirm the promising activity of novel anti-HER2 agents in HER2-low gastro-oesophageal cancers, a shift in the interpretation of HER2 status may need to be pursued.
Keyphrases
  • mental health
  • fine needle aspiration
  • squamous cell carcinoma
  • ultrasound guided